How did Jeffrey Aronin become a pioneer and innovator? He started his career after earning a bachelors degree from Northern Illinois University and an MBA from DePaul University. He developed a passion for helping patients while shadowing a physician. The physician had a major treatment decision to make concerning a child who suffered with seizures. Should the treatment be surgery or medicine? The doctor decided to use medicine. This decision opened Jeffery Aronin’s mind to the power of pharmaceuticals. This passion has fueled his innovative journey. In 2000, Jeffrey Aronin made his first major move as CEO and founder of his startup Ovation Pharmaceuticals, LLC. He created the company to focus on patients with rare or neglected diseases. The company was purchased by Lundbeck in 2009 for $900 million. Jeffrey stayed on board as president and CEO to oversee the transition. Today, Jeffrey Aronin serves as chairman and CEO of Paragon Biosciences. Unlike most biomedical companies whose focus is on the next great thing, Jeffrey’s patient-focused vision has earned him the title of pioneer. Paragon has invested in several other companies which includes Castle Creek Pharma, Harmony Biosciences, Skyline Biosciences, and Emalex Biosciences. Jeffrey’s staff of scientists have been with him for over 15 years. He credits this as part of his success. His team shares his vision and passion. That vision has placed Paragon and Jeffrey Aronin at the top of the industry. Jeff and his R&D have worked tirelessly to gain approval for 32 novel and new drugs from the FDA. These life changing drugs have changed the lives of many people who otherwise would be forgotten. Insights Care magazine recognized Jeffrey Aronin for his advanced and original ideas in his industry. They also recognized him for creating drugs which could mean the difference between life and death for some patients. Hats off to Jeffrey Aronin – The Passionate Pioneer and Innovator of Healthcare.